Saffron Walden, 26th January 2022 / Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. The agreement provides an exclusive licence to research, develop, manufacture and commercialise FLIP inhibitors. Domainex has supported the FLIP inhibitor programme from its inception. Leia Mais »

A number of exciting new sickle cell disease (SCD) drugs are set to hit the US market, says GlobalData, including gene therapies that could offer patients a cure. The leading data and analytics company notes that one of the gene therapies that is currently closest to entering the market— bluebird bio’s bb1111—is projected to represent over a quarter of total sales within the space by 2030. Meanwhile, Droxia, a drug that once was the only approved drug for 20 years, will be drowned out by the newcomers. Leia Mais »

Cenário Econômico de 2021 e 2022, oportunidades de negócios, Normas Regulamentadoras e capacitação são temas do encontro promovido pela ABRAVA que acontecerá no dia 27 de janeiro, e que tem por objetivo a promoção e geração de oportunidades para os setores representados. Leia Mais »

Ter uma estrutura óssea adequada é fundamental para o bem-estar e qualidade de vida dos animais Leia Mais »

O ano de 2021 foi ainda de pandemia e começou muito incerto para vários setores, contudo, para o varejo farmacêutico, mesmo com esse cenário, os números continuaram a ser positivos. Leia Mais »